Total Funding
89
50
Total FundingSeries A raised
Growth Score
-6 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23831
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.
Court Turner: Co-Founder and Chief Executive OfficerPast Role: Synthorx, President, CEO and Director- Lev Becker: Co-FounderPast Role: rMark Bio, Co-Founder
About the Company
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company's drug selectively targets cancer cells and is non-toxic to normal cells and tissues, helping medical professionals treat cancer patients efficiently.
It was founded in 2017 and is headquartered in San Diego,
California.
